
0:00
47:44
Dr. David Katz, President and CEO of Diet ID, joins Double Take to examine how GLP-1s may affect far more than weight loss—from food noise and addiction to healthcare costs, side effects and shifts in consumer behavior across sectors.
More episodes from "Double Take By BNY Investments"



Don't miss an episode of “Double Take By BNY Investments” and subscribe to it in the GetPodcast app.








